KMT2A and acute myeloid leukemia: More than 60% of all rearrangements found in pediatric AML target only five different protein complexes: the core binding factor (CBF), the epigenetic regulator MLL, the nuclear receptor RARA, and the nuclear pore component NUP98 [1,2].